“SYSTEMATIC REVIEW OF THE COST-EFFECTIVENESS OF ABEMACICLIB IN THE TREATMENT OF HR+ HER2− ADVANCED OR METASTATIC BREAST CANCER ”. Vietnam Journal of Community Medicine, vol. 67, no. 10, Nov. 2026, https://doi.org/10.52163/yhc.v67i10.6967.